Case Series of 10 Drug-Refractory IBS Patients Who Respond to Oral Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI)

ISSN Print: 2163-9450
ISSN Online: 2163-9469
www.scirp.net/journal/ojgas/
E-mail: [email protected]

Citations

"Case Series of 10 Drug-Refractory IBS Patients Who Respond to Oral Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI)"
written by Raouf Hilal, Patricia Mitchell, Ernesto Guerra Jr., Bruce P. Burnett,
published by Open Journal of Gastroenterology, Vol.4 No.10, 2014

has been cited by the following article(s):

[1]	The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders
	2017

[2]	Oral serum bovine immunoglobulin improves IBS-D symptoms analyzed from patient medical charts.
	2017

[3]	Oral serum bovine immunoglobulin improves IBS-D symptoms analyzed from patient medical charts
	2017

[4]	Articles in PresS. Am J Physiol Gastrointest Liver Physiol (April 16, 2015). doi: 10.1152/ajpgi. 00378.2014
	2015

[5]	Post-infectious irritable bowel syndrome with functional diarrhea following C. difficile infections: case studies of responses using serum-derived bovine …
	2015

[6]	Post-Infectious Irritable Bowel Syndrome with Functional Diarrhea Following C. difficile Infections: Case Studies of Responses Using Serum-Derived Bovine Immunoglobulin
	Journal of Gastroenterology and Hepatology Research, 2015

[7]	Management of inflammatory bowel disease with oral serum-derived bovine immunoglobulin
	Therapeutic Advances in Gastroenterology, 2015

[8]	Dietary intervention with serum-derived bovine immunoglobulins protects barrier function in a mouse model of colitis
	American Journal of Physiology-Gastrointestinal and Liver Physiology, 2015